Four Step Preclinical Strategy to Tackle Cancer Drug Resistance

Cancer drug resistance is an area of high unmet medical need, impacting the success of therapeutics and contributing to cancer-related deaths. Resistance can be challenging to understand, model, and target due to its multifaceted complexity. In this webinar, we: Discuss the challenges of cancer drug resistance, the evolving landscape of clinical need, and how an integrated approach can be beneficial in early drug discovery Outline a four-step strategy to identify the most effective preclinical tools in response to the emergence of new resistance phenotypes, including both intrinsic and acquired and the tools needed for deep characterization Provide examples of models with resistance to targeted therapy or immuno-therapeutics, describing the key features, challenges, and their applications Subscribe to the Crown Bioscience YouTube channel:    / @crownbioscience   For more news, insights, and resources, check out our website and social media channels: Website - https://www.crownbio.com/ LinkedIn -   / crown-bioscience-inc-   X -   / crownbioscience   Facebook -   / crownbio   Instagram -   / crown.bioscience   Threads - https://www.threads.net/crown.bioscie...